Chinese chip foundry CanSemi’s IPO oversubscribed 2,360 times as investors chase AI boom
Chinese chip foundry CanSemi Technology’s Shenzhen IPO is one of mainland China’s most sought-after tech listings this year. Investors are betting on its push into silicon photonics and its role in domestic AI infrastructure. CanSemi will be the first pure-play wafer fabrication company to list on Shenzhen’s ChiNext board. This debut marks a significant milestone for the exchange.
CanSemi's IPO oversubscription reflects China's urgent push for domestic AI infrastructure. The 2,360 times oversubscription shows investor confidence in silicon photonics. This technology is critical for advanced AI computing. China aims to reduce reliance on foreign chip technology for its AI ambitions.
The listing on Shenzhen’s ChiNext board provides a new avenue for domestic capital. This allows Chinese investors to back key national tech priorities. CanSemi's success could encourage more pure-play wafer foundries to list locally. This strengthens China's semiconductor supply chain.
The test for CanSemi is whether it can scale silicon photonics production quickly. Its ability to deliver on domestic AI chip demand will be crucial. Watch for production capacity targets over the next 12 months. This will indicate its true market impact.
Share this article
Related reading
6 stories
ByteDance grabs one-fifth of China’s data centre capacity as AI drives infrastructure boom
China's AI infrastructure boom, driving demand for chips like CanSemi's, is also fueling data centre expansion.
Mainland Chinese stocks hit 13-month low on tech sell-off as Hong Kong market holds up
CanSemi's IPO success comes as mainland Chinese tech stocks have faced broader market challenges.
US risks ceding AI governance leadership to China and the EU
BDO Unibank Powers Smarter, Next-Generation Payments With Finastra
